Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study

Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study

Abstract Background Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. Methods Our objective was to describe and assess patterns in the use of neuromuscular blocking agents (NMBAs), neuromuscular transmission (NMT) monitoring, and factors associa...

Full description

Bibliographic Details
Main Authors:	Piet Krijtenburg, Arjen de Boer, Lori D. Bash, Gert Jan Scheffer, Christiaan Keijzer, Michiel C. Warlé
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	Perioperative Medicine
Subjects:	Neuromuscular transmission (NMT) monitoring Neuromuscular blocking agents (NMBAs) Reversal agents for NMBAs
Online Access:	https://doi.org/10.1186/s13741-024-00382-y

Similar Items

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
by: HaoTian Wu, et al.
Published: (2022-04-01)

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
by: Zhongjun Zheng, et al.
Published: (2020-01-01)

Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database
by: Xiaojun Pan, et al.
Published: (2023-02-01)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
by: Khawaja Rashid Hafeez, et al.
Published: (2018-07-01)

A surgeon′s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
by: James J Lamberg, et al.
Published: (2013-01-01)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
by: Sung-Ae Cho, et al.
Published: (2022-04-01)

Reversal agents: do we need to administer with neuromuscular monitoring – an observational study
by: Shilpa Goyal, et al.
Published: (2018-01-01)

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study)
by: Massimiliano Greco, et al.
Published: (2023-01-01)

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
by: Hans D de Boer, et al.
Published: (2018-11-01)

Phenobarbital influence on neuromuscular block produced by rocuronium in rats Influência do fenobarbital no bloqueio neuromuscular produzido pelo rocurônio em ratos
by: Angélica de Fátima de Assunção Braga, et al.
Published: (2008-08-01)

Neuromuscular block in patients 80 years and older: a prospective, controlled study
by: Denis Schmartz, et al.
Published: (2021-09-01)

A Cross-Sectional survey on Knowledge, Attitude, and Practices of Neuromuscular Monitoring among Indian Anesthesiologists
by: Sonal Goyal, et al.
Published: (2022-10-01)

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
by: Hey-Ran Choi, et al.
Published: (2022-04-01)

The latest trend in neuromuscular monitoring: return of the electromyography
by: Wonjin Lee
Published: (2021-04-01)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
by: Yong Byum Kim, et al.
Published: (2017-10-01)

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study
by: Ákos I. Fábián, et al.
Published: (2021-08-01)

Neuromuscular blockade management in the critically Ill patient
by: J. Ross Renew, et al.
Published: (2020-05-01)

Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm
by: Yong Beom Kim, et al.
Published: (2020-06-01)

Feasibility of intraoperative quantitative neuromuscular blockade monitoring in children using electromyography
by: Kwaku Owusu-Bediako, et al.
Published: (2022-01-01)

Neuromuscular blockade management in patients with COVID-19
by: Harold Chaves-Cardona, et al.
Published: (2021-08-01)

Progress of residual neuromuscular blockade after general anesthesia in elderly patients
by: LIU Qiuli, et al.
Published: (2023-01-01)

Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review
by: Franziska Elisabeth Blum, et al.
Published: (2024-02-01)

The tof-guard neuromuscular transmission monitor and its use in horses O monitor da transmissão neuromuscular "tof-guard" e seu uso em eqüinos
by: Juliana Noda Bechara, et al.
Published: (1999-03-01)

Rate of residual neuromuscular block using single-dose rocuronium in general anesthesia for ENT surgery: a retrospective cohort study
by: Orlando Carrillo-Torres, et al.
Published: (2023-04-01)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
by: Tom Schepens, et al.
Published: (2019-10-01)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
by: Ricardo Vieira Carlos, et al.
Published: (2018-08-01)

Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
by: Amédée Ego, et al.
Published: (2021-11-01)

Effects of sevoflurane and adenosine receptor antagonist on the sugammadex‐induced recovery from rocuronium‐induced neuromuscular blockade in rodent phrenic nerve–hemidiaphragm tissue specimens
by: Yong Beom Kim, et al.
Published: (2021-08-01)

Small doses of epinephrine prolong the recovery from a rocuronium-induced neuromuscular block: a case report
by: Hubert J. Schmitt
Published: (2018-07-01)

Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
by: Luo J, et al.
Published: (2018-12-01)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
by: Gonzalo Domenech, et al.
Published: (2019-08-01)

MRI measurement of the effects of moderate and deep neuromuscular blockade on the abdominal working space during laparoscopic surgery, a clinical study
by: Piet Krijtenburg, et al.
Published: (2023-07-01)

Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center
by: Juan Fiorda Diaz, et al.
Published: (2022-12-01)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
by: Wei Chang, et al.
Published: (2020-02-01)

Bonfils Fiberscope: Intubating Conditions and Hemodynamic Changes without Neuromuscular Blockade
by: Atabak Najafi, et al.
Published: (2011-04-01)

Bonfils Fiberscope: Intubating Conditions and Hemodynamic Changes without Neuromuscular Blockade
by: Atabak Najafi, et al.
Published: (2011-04-01)

Antibiotic-induced immediate type hypersensitivity is a risk factor for positive allergy skin tests for neuromuscular blocking agents
by: Natalia Hagau, et al.
Published: (2016-01-01)

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
by: Carron M, et al.
Published: (2016-02-01)

Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation
by: Karen Miller, et al.
Published: (2017-01-01)

Neuromuscular blocking agents and opioids are major risk factors for developing pressure injuries in patients in the intensive care unit
by: Su Yeon Lee, et al.
Published: (2022-11-01)